Related Experiment Videos
Avian infectious bronchitis: cross-protection studies using different Australian subtypes
1National Biological Standards Laboratory, Parkville, Victoria.
Australian Veterinary Journal
|November 1, 1989
Summary
This study assessed cross-immunity in chickens vaccinated against infectious bronchitis virus (IBV). Results indicate that while cross-protection occurred, it varied between vaccine strains, and antibody levels did not reliably predict protection.
Area of Science:
- Veterinary Virology
- Immunology
- Poultry Health
Background:
- Infectious Bronchitis Virus (IBV) is a significant respiratory pathogen in poultry.
- Understanding cross-immunity between IBV strains is crucial for effective vaccination strategies.
- Current vaccines (Vac 3, Vac 4) and field strains (Q1/76, N2/62) were evaluated.
Purpose of the Study:
- To assess the cross-protective immunity in chickens vaccinated with different IBV strains.
- To evaluate the correlation between humoral antibody responses and protection against IBV challenge.
- To compare the efficacy of current vaccine strains versus field strains in conferring cross-immunity.
Main Methods:
- Chickens were vaccinated with four distinct IBV strains: Vac 3, Vac 4, Q1/76, and N2/62.
- Vaccinated chickens were subsequently challenged with IBV N1/62 (T0) and IBV N9/74 (Appin).
- Humoral antibody responses and ciliary activity in tracheal rings were measured to assess protection.
Main Results:
- A lack of correlation was observed between humoral antibody levels and the degree of protection.
- Cross-immunity was demonstrated following vaccination with each tested IBV subtype.
- Vaccination with Q1/76 and N2/62 conferred higher levels of cross-immunity compared to Vac 3 and Vac 4.
Conclusions:
- Humoral antibody titers are not a reliable indicator of protection against IBV challenge.
- The efficacy of cross-immunity varies significantly among different IBV vaccine and field strains.
- Field strains Q1/76 and N2/62 appear to induce broader cross-protection than current vaccine strains Vac 3 and Vac 4.